Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Diana Hausman currently holds 3,000 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Diana Hausman has been a net seller of ZNTL stock. They have purchased $46.6K and sold $3.3M worth of shares.
Diana Hausman's most recent insider trade was on Jul 2, 2025, when they purchased 3,000 shares at $3.62 per share.
Diana Hausman serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 29 insider transactions totaling $3.3M over their tenure at the company.
Diana Hausman holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Diana Hausman has shown a selling trading pattern, with $46.6K in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Diana Hausman was on Sep 14, 2020, when they sold $1.8M worth of ZYME shares. This transaction involved 40,000 shares at $45.00 per share.
Diana Hausman currently owns 3,000 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Diana Hausman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Diana Hausman has 29 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for Diana Hausman and 40,000+ other insiders.